Novel angiogenesis inhibitors

Details Novel angiogenesis inhibitors Novel angiogenesis inhibitors

C - Chemistry, Metallurgy

07

D

C07D 471/04 (2006.01) A61K 31/4439 (2006.01) A61K 31/444 (2006.01) C07D 401/14 (2006.01) C07D 409/14 (2006.01)

Patent

CA 2356349

The present invention relates to compounds which inhibit tyrosine kinase enzymes, compositions which contain tyrosine kinase inhibiting compounds and methods of using tyrosine kinase inhibitors to treat tyrosine kinase-dependent diseases and conditions such as angiogenenesis, cancer, atherosclerosis, diabetic retinopathy, and the like in mammals.

La présente invention concerne des composés d'inhibition des enzymes tyrosine-kinase, des compositions qui contiennent des composés d'inhibition de la tyrosine-kinase et des procédés d'utilisation de composés d'inhibition de la tyrosine-kinase qui permettent de traiter les troubles liés à la tyrosine-kinase et les états pathologiques tels que l'angiogénèse, le cancer, l'athérosclérose, la rétinopathie diabétique, et analogue chez les mammifères.

Affiliated with

Also associated with

Rating

Novel angiogenesis inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel angiogenesis inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel angiogenesis inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1915397